Literature DB >> 7700655

Treatment of tympanic membrane retraction with the holmium laser.

H Kurokawa1, R L Goode.   

Abstract

Politzerization, the Valsalva maneuver, and ventilation tube insertion are available treatments for tympanic membrane retraction. Ventilation of the middle ear cavity can correct tympanic membrane retraction in many cases, but not in all. Retraction may be localized or diffuse. This article describes experiments performed to evaluate a new method to "tighten" retracted or flaccid tympanic membranes with a holmium laser in a human temporal bone model. Ten temporal bones with mild-to-moderate retraction of the posterior superior quadrant or pars flaccida were treated with a series of laser pulses around and to the area of retraction. Umbo displacement before and after laser treatment was performed with a laser Doppler vibrometer to evaluate the effect on the acoustic function of the tympanic membrane. In all ears, the posterior superior quadrant retraction appeared to be completely corrected. Laser treatment of the posterior superior quadrant retraction produced improvement in umbo displacement below 1.0 kHz. After treatment of pars flaccida retraction, the configuration was improved a small amount; however, no increase in umbo displacement was found.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700655     DOI: 10.1177/019459989511200402

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

Review 1.  Tympanic membrane retraction pocket staging: is it worthwhile?

Authors:  Musaed Alzahrani; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-27       Impact factor: 2.503

2.  Transmeatal excision of pars tensa retraction pockets with simultaneous ventilation tube insertion in children: a prospective study.

Authors:  Gábor Ráth; Imre Gerlinger; Zsuzsanna Csákányi; Mónika Sultész; Veronika Gaál; Gábor Katona
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-18       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.